Skip to main content
NCBI home page
Medical Science Monitor: International Medical Journal of Experimental and Clinical Research logoLink to Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
. 2020 Jan 4;26:e920265-1–e920265-8. doi: 10.12659/MSM.920265

Induction of Apoptosis in Lung Cancer Cells by Viburnum grandiflorum via Mitochondrial Pathway

Bing Han 1,A,E,F,✉, Jianqiang Wu 1,B,C,D, Lei Huang 1,B,C,E,F
PMCID: PMC6977709  PMID: 31900380

Abstract

Background

Lung cancer is one of the leading causes of mortality and morbidity. Viburnum grandiflorum is a medicinal herb known for its wide spectrum of pharmacological activities, but its anti-cancer properties against lung cancer cells have not been previously investigated. The present study elucidated the antitumor effect and associated mechanism of methanol extract of Viburnum grandiflorum extract (VGE) against lung cancer cells.

Material/Methods

The viability of H1650, HCC827, and H1299 cells was measured using MTT assay. Apoptosis and cell cycle progression were determined by flow cytometry using annexin-V/PI and JC-1 stains, respectively. The Lipofectamine Plus reagent (Invitrogen) was used for transfection of caspase-9 plasmid to H1650 and H1299 cells.

Results

The results showed decreased H1650, HCC827, and H1299 cell viability by VGE, which occurred in a concentration- and time-dependent manner. The VGE treatment significantly increased the rate of apoptosis in H1650 (P<0.05) and H1299 (P<0.02) cells at 48 and 72 h. Treatment of H1650 and H1299 cells with 10 μM of VGE significantly enhanced the number of cells in sub-G1 phase. The VGE treatment cleaved pro-caspase-8/-9 and-3 in H1650 and HCC827 cells at 72 h. The VGE treatment of H1650 and HCC827 cells reduced Mcl-1 protein expression. Treatment of H1650 and HCC827 cells with VGE markedly decreased the level of p-Akt. However, dominant-negative caspase-9 (caspase-9 dN) plasmid transfection prevented the viability-inhibitory effect of VGE on H1650 and HCC827 cells. Treatment of H1650 and HCC827 cells with VGE increased levels of cytochrome c in the cytosol.

Conclusions

VGE inhibited lung carcinoma cell viability by apoptosis activation through a caspase-dependent pathway. Therefore, VGE is a potent anti-cancer agent against lung cancer cells.

MeSH Keywords: Apoptosis, Molecular Conformation, Proteolysis

Background

Lung cancer is diagnosed in more than 225 000 people every year in the United States alone and is the common cause of deaths associated with cancer [1]. The most common type of lung carcinoma is non-small cell lung cancer, which accounts for 80% of all lung cancer cases [1]. Although radiotherapy and chemotherapy employed for the treatment of lung cancer have undergone drastic improvement over the past decade, the prognosis of patients is still dismal [2]. The of 5-year survival rate for patients with lung carcinoma is around 15% [2]. Radical resection followed by administration of adjuvant chemotherapy to patients with primary tumors has been reported to induce recurrences in most cases [3–5]. There is urgent need for improvement in lung carcinoma treatment through identification of molecular targets and by discovering novel anti-cancer compounds.

Apoptosis is the process by which cells are killed through the activation of caspases, leading to the cleavage of proteins and ultimately to cell death [6–9]. The apoptotic stimuli catalyse efflux of mitochondrial molecules to the cytosol, where pro-apoptotic processes are initiated [8,9]. For example, secretion of cytochrome c into the cytosol causes oligomerization of Apaf-1 (adaptor protein), followed by the proteolytic cleavage of pro-caspases [10]. The release of apoptosis-regulatory molecules from mitochondria depends on membrane permeability, which is controlled by Bcl-2 family proteins [11]. There are pro-apoptotic (Bid and Bim) and anti-apoptotic factors 9 (Bcl-2, Bcl-xL, and Mcl-1) in the Bcl-2 family [11–13]. The unique feature of Mcl-1 anti-apoptotic protein which distinguish it from other members is that it binds to a different BH3 subset [14,15]. Mcl-1 expression has been found to inhibit ultraviolet radiation-induced apoptosis [16]. It has also been found that Mcl-1 leads to anti-apoptotic effects through targeting the expression of Bak [17]. Recently, it was found that Mcl-1 induces conformational irregularity in Bax and inhibits cytochrome c translocation [18]. Various compounds have been found to be useful for the treatment of cancers through activation of various pathways [19–21]. The present study investigated the ability of methanol extract of Viburnum grandiflorum to inhibit lung cancer cell growth.

Material and Methods

Preparation of plant extract

The plant material was collected in the month of September, dried in the shade, chopped, and then powdered using grinders. Identification of the plant was made by Wei Zhang and the specimen sample was deposited in the herbarium. The powder was suspended in dichloromethane for 72 h to extract the non-polar compounds present in the plant. The solvent was filtered and then evaporated using a rotatory evaporator to obtain the extract. Extraction with dichloromethane was performed 3 times to collect most of the non-polar compounds. Then, methanol was poured on the plant material so all the material was completely suspended in it. After 72 h, the methanol was filtered and evaporated using the rotatory evaporator to collect the methanol extract of Viburnum grandiflorum. The extract was completely dried for further experiments.

Cell culture

The H1650, HCC827, and H1299 cell lines were provided by the American Type Culture Collection (Manassas, VA, USA). All the cell lines were cultured in DMEM medium (Gibco BRL, Gaithersburg, MD, USA) mixed with 10% fetal bovine serum (FBS). The cells were incubated at 37°C in an atmosphere of 5% CO2 and 95% air.

Cell viability assay

The evaluation of H1650, HCC827, and H1299 cell viability was performed using MTT [3- (4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. The 3 cell lines were grown for 12 h in 96-well plates and then were treated with 2, 4, 6, 8, 10, and 12 μM of VGE for 48 and 72 h. Next, 100 μl of MTT (5 mg/ml) was put into each well and cells were incubated for 2 h. Then, Me2SO was added to the plates to dissolve the formazan crystals formed from MTT by interaction with the mitochondrial enzymes. The measurement of absorbance was carried out at 568 nm using a microplate reader (Molecular Devices, CA, USA).

Apoptosis analysis using flow cytometric assay

The H1650 and H1299 cells at a density of approximately 1×106 cells per well in 6-well plates were treated with 10 μM VGE for 48 and 72 h. Then, cells were suspended in PBS (100 μl) and subsequently treated with 200 μl of ethyl alcohol. Following incubation for 1 h, the cells were washed in PBS and then treated with 1.2% sodium citrate buffer (200 μl) and RNase (12.5 μg). After 45 min of incubation at 37°C, the cells were stained with 50 μg/ml solution of PI at room temperature for 40 min. The FAC Scan flow cytometer was used for determination of relative DNA content using fluorescence-activated cell sorting (FACS). The mitochondrial membrane potential was measured using JC-1 stain, which, on penetrating the mitochondria, forms monomers and emits green fluorescence when the mitochondrial membrane potential is low, whereas high membrane potential is characterised by the aggregation of JC-1 and emission of red fluorescence. The wavelength of excitation was 486 nm, while FL1 and FL2 emissions were detected at 523 nm and 576 nm, respectively.

Cell cycle analysis

The H1650 and H1299 cells were distributed at 2×106 cells per well density in 60-mm plates and incubated for 48 and 72 h with 10 μM VGE. The cells were washed 2 times with PBS after trypsinization, followed by fixing with 70% ice-cold ethyl alcohol overnight. Then, cells were treated at 37°C with 20 μg/ml RNase A for 1 h and subsequently stained with 10 μg/ml PI. The distribution of cells was analyzed by flow cytometry using a FACS Calibur instrument (BD Biosciences, San Jose, CA, USA).

Western blotting

The H1650 and H1299 cells at approximately 1×105 cells per well density were treated with 10 μM VGE for 48 and 72 h. The plates were kept on ice and lysed on treatment with pre-chilled proteinase inhibitor, which consisted of phenyl methyl sulfonyl fluoride and phosphatise. The protein extraction from the cells was performed using an extraction kit (Sangon Biotech Co., Shanghai, China). The cell lysate was cleared of the debris by filtration after centrifugation. A bicinchoninic acid (BCA) kit was used for determination of protein concentration in the supernatant. The protein samples (50 μg) were separated with a 10% gel using SDS-PAGE and then transferred on polyvinylidene difluoride membranes. The membranes were blocked overnight at 4°C with 5% non-fat dry milk in phosphate-buffered saline (PBS) plus Tween-20. The membrane incubation was performed with primary antibodies against pro-caspase-8,-3, Bcl-2, PARP, and p-Akt overnight at 4°C. The membranes washed with tris-buffered saline and Tween-20 were incubated for 2 h with horseradish peroxidase-labelled goat anti-rabbit IgG secondary antibody. The protein band detection was performed using chemiluminescence and autoradiography (ChemiDoc XRS; Bio-Rad Laboratories, Inc., Hercules, CA, USA). Determination of densitometry was carried out using Quantity One software version 4.6.2 (Bio-Rad Laboratories, Inc., Hercules, CA, USA).

Reverse transcription-polymerase chain reaction (RT-PCR)

Total RNA extraction from H1650 and H1299 cells at 48 and 72 h of treatment with 10 μM VGE was performed using TRIzol reagent (Invitrogen, Carlsbad, CA, USA). The RNA samples (2 μg) were used for synthesis of complementary DNA using the MMLV reverse transcriptase (Takara Co., Japan). The amplification of Mcl-1 mRNA was done using forward 5′-CCT TCCAAG GAT GGG TTT GT-3′ and reverse 5′-TCTTCA ATC AAT GGG GAG CA-3′ primers. The PCR cycling conditions used for Mcl-1 amplification consisted of: 94°C for 30 s, 93°C for 2 s, and 58°C for 30 s for 40 cycles. The value of the average threshold for each cycle was normalized to GAPDH and the level of expression was quantified using the 2–ΔΔCq method.

Transfection of H1650 and H1299 cells with dominant-negative caspase-9

Lipofectamine Plus reagent (Invitrogen) was used for transfection of caspase-9 (caspase-9 dN) plasmid to H1650 and H1299 cells. The cells seeded at 1×105 cells per well density in 6-well plates were cultured in DMEM mixed with 10% FBS, and incubation was carried out for 24 h. After washing twice with Opti-MEM medium, the cells were incubated with Opti-MEM medium and caspase-9 dN for 4 h. The medium was changed with DMEM containing 10% FBS and incubation was continued for 24 h. The pcDNA 3.1-caspase-9 plasmid or control pcDNA 3.1 vector plasmid was stably transfected to H1650 and H1299 cells using Lipofectamine.

Determination of cytochrome c release

The H1650 and H1299 cells after 48 and 72 h of treatment with 10 μM VGE were harvested and then washed in PBS. The cells were put in lysis buffer consisting of HEPES (25 mM, pH 7.5), sucrose (250 mM), EDTA (1 mM) EGTA (1 mM), DTT (1 mM), potassium chloride (10 mM), magnesium chloride (1.5 mM), PMSF (1 mM), and protease inhibitor cocktail for 15 min. The lysate obtained was subjected to centrifugation for 25 min at 4°C to collect mitochondria-free cytosolic extract and mitochondrial extract. Immunoblotting was performed to determine cytochrome c expression in the supernatants.

Statistical analysis

Data are presented are the mean±standard deviation. All experiments were carried out in triplicate. One-way analysis of variance and post hoc Geisser-Greenhouse correction were used for determination of statistically significant differences, set at P<0.05. SPSS v17 software (SPSS, Inc., Chicago, IL, USA) was used for statistical analysis of the data.

Results

Viburnum grandiflorum has inhibitory effect on lung cancer cell viability

The cytotoxicity of VGE was analyzed against H1650, HCC827, and H1299 cells by MTT. The results showed decreased H1650, HCC827, and H1299 cell viability by VGE in a concentration- and time-dependent manner. VGE treatment at 10 μM for 48 h reduced viability of H1650, HCC827, and H1299 cells to 48%, 45%, and 41%, respectively (Figure 1). Treatment of H1650, HCC827, and H1299 cells with VGE at 10 μM for 72 h decreased viability to 34%, 31%, and 29%, respectively (Figure 2).

Figure 1.

Figure 1

Open in a new tab

Effect of VGE on lung cancer cell viability. The H1650, HCC827 and H1299 cells were treated with VGE at 2, 4, 6, 8, 10, and 12 μM for 48 h. The cell viability was measured by MTT assay using dimethyl sulfoxide-treated cells as control. * P<0.05, ** P<0.02, and *** P<0.01 vs. control.

Figure 2.

Figure 2

Open in a new tab

Effect of time of exposure of VGE on lung cancer cell viability. The H1650, HCC827, and H1299 cells were treated with VGE for 6, 12, 18, 24, 48, and 72 h. Cell viability was measured by MTT assay using dimethyl sulfoxide-treated cells as control. * P<0.05, ** P<0.02, and *** P<0.01 vs. control.

Viburnum grandiflorum induces apoptosis in lung cancer cells

Induction apoptosis by VGE treatment was assessed in H1650 and H1299 cells by flow cytometric analysis (Figure 3). The VGE treatment significantly increased the rate of apoptosis in H1650 (P<0.05) and H1299 (P<0.02) cells at 48 and 72 h. However, the data showed that the percentage of apoptotic cells was markedly higher at 72 h of treatment with VGE.

Figure 3.

Figure 3

Open in a new tab

Effect of VGE on apoptosis induction in H1650 and H1299 cells. The H1650 and H1299 cells were treated with VGE at 10 μM for 48 and 72 h. The apoptosis induction by VGE was measured at 48 and 72 h by flow cytometry using dimethyl sulfoxide-treated cells as control. * P<0.02 and ** P<0.01 vs. control.

Viburnum grandiflorum increased the sub-G1 phase cell population

VGE treatment of H1650 and H1299 cells significantly enhanced the number of cells in sub-G1 phase at 10 μM (Figure 4). The increase in sub-G1 phase cell numbers was much higher at 72 h than at 48 h treatment. The percentage of H1650 and H1299 cells in S and G2/M phases was reduced after treatment with VGE for 48 and 72 h.

Figure 4.

Figure 4

Open in a new tab

VGE enhanced the numbers of H1650 and H1299 cells in sub-G1 phase. The H1650 and H1299 cells were treated with VGE at 10 μM for 48 and 72 h. The changes in cell cycle progression caused by VGE were determined by flow cytometry using dimethyl sulfoxide-treated cells as control. * P<0.02 and ** P<0.01 vs. control.

Viburnum grandiflorum activated caspases

The changes in caspase activation by VGE in H1650 and HCC827 cells were assessed by Western blot assay (Figure 5). Treatment with VGE cleaved pro-caspase-8 and-9 in H1650 and HCC827 cells at 72 h. The cleavage of caspase-3 was also promoted by VGE treatment in H1650 and HCC827 cells. The cleavage of PARP in H1650 and HCC827 cells was promoted by treatment with 10 μM of VGE.

Figure 5.

Figure 5

Open in a new tab

Effect of VGE on activation of caspases in lung cancer cells. In H1650 and HCC827 cells, activation of caspase-8/-9/-3 and PARP was assessed by Western blotting. The β-actin level was taken as a loading control.

Effect of Viburnum grandiflorum on Bcl-2 proteins in lung cancer cells

The VGE treatment of H1650 and HCC827 cells reduced the expression of Mcl-1 protein at 72 h (Figure 6). The level of Mcl-1 mRNA was also lower in H1650 and HCC827 cells after treatment with 10 μM of VGE (Figure 6).

Figure 6.

Figure 6

Open in a new tab

Effect of VGE on level of Bcl-2 proteins. The H1650 and HCC827 cells treated with VGE at 10 μM for 72 h were assessed by Western blot assay. β-actin was used as a loading control. The Mcl-1 mRNA level was determined by RT-PCR assay.

Viburnum grandiflorum reduced Akt activation in lung cancer cells

H1650 and HCC827 cells treated with VGE at 10 μM had markedly reduced levels of p-Akt at 72 h (Figure 7A). Transfection of H1650 and HCC827 cells with dominant-negative caspase-9 (caspase-9 dN) plasmid prevented the viability-inhibitory effect of VGE (Figure 7B). VGE treatment significantly reduced the viability of vector-transfected cells.

Figure 7.

Figure 7

Open in a new tab

Effect of VGE on PI3K/Akt signalling. (A) The H1650 and HCC827 cells treated with VGE were analyzed by Western blot assay for p-Akt expression. β-actin was used as a loading control. (B) The cells transfected with caspase-9 dN or vector were assessed by MTT assay for changes in viability. * P<0.02 and ** P<0.01 vs. control.

Viburnum grandiflorum activated apoptosis through mitochondrial pathway

Treatment of H1650 and HCC827 cells with VGE increased cytochrome c in the cytosol (Figure 8). The level of cytochrome c in control H1650 and HCC827 cells was markedly lower in comparison to the VGE-treated cells.

Figure 8.

Figure 8

Open in a new tab

Effect of VGE on the mitochondrial apoptotic pathway. Cells at 72 h of VGE treatment were analyzed by Western blot analysis for cytochrome c release.

Discussion

The present study demonstrated the role of VGE in inhibiting the viability of lung carcinoma cells. The data showed that VGE reduced lung cancer cell viability by activating apoptosis through the involvement of various factors like caspases, Akt, and Mcl-1.

Cellular apoptosis in several kinds of carcinoma cells is blocked by the PI3K/Akt pathway [22]. The expression of PI3K/Akt has been found to be much higher in cancer cells and is believed to impart resistance against anti-cancer compounds [23]. Targeting of the PI3K/Akt pathway leads to apoptosis activation in myelogenous leukemia cells, which are resistant to drugs [24]. In multiple myeloma cells that are resistant to dexamethasone, apoptosis induction by PS-341 is promoted by triptolide by targeting the PI3K/Akt/NF-κB pathway [25]. In the present study, VGE reduced H1650, HCC827, and H1299 cell viability in a time- and concentration-dependent manner. The decrease inH1650, HCC827, and H1299 cell viability by VGE was greatest after treatment with 10 μM at 72 h. The mechanistic study revealed that VGE treatment activated the apoptotic pathway for inhibition of H1650 and H1299 cell viability. The expression of the pro-survival protein p-Akt was reduced in H1650 and H1299 cells after treatment with VGE. The essential event for apoptosis induction is the release of cytochrome c, the inter-membrane protein, into the cytosol [26,27]. Cytochrome c is involved in the formation of apoptosomes and activates caspases in the cytosol [26,27]. In the present study, VGE treatment increased cytochrome c release in the cytosol of H1650 and H1299 cells. Apoptosis induction is dependent on the expression of various proteins like caspases, which actually execute cell death following apoptotic stimuli [28]. The present study assessed the effect of VGE on expression of caspase-8/-9/-3 and cleaved PARP in H1650 and H1299 cells. The data from Western blotting revealed that VGE treatment of H1650 and H1299 cells promoted activation of caspase-8/-9/-3 and cleavage of PARP. In order to confirm that VGE leads to lung carcinoma cell apoptosis through the caspase-dependent pathway, H1650 and H1299 cells were transfected with caspase-9 dN. The data showed that caspase-9 dN transfection of H1650 and H1299 cells prevented VGE-induced viability reduction. These findings suggest that VGE activated apoptosis in H1650 and H1299 cells through a caspase-dependent pathway.

Bcl-2 family proteins like Mcl-1 and Bcl-2 downregulate the process of apoptosis and inhibit activation of caspases by regulating the integrity of mitochondrial membranes [29–31]. It was reported that overexpression of Mcl-1 inhibits cytochrome c release, cleavage of PARP, and caspase activation in HeLa cells irradiated with UV-radiations [16]. Mcl-1 has been found to inhibit the ability of Bid to promote cytochrome c secretion and induce apoptosis [32]. In the present study, expression of Mcl-1 was reduced in H1650 and H1299 cells after treatment with VGE. VGE treatment also leads to mitochondrial membrane potential loss in H1650 and H1299 cells.

Conclusions

VGE inhibited lung carcinoma cell viability by activation of apoptosis. The mechanism of VGE-induced apoptosis involved caspase activation, downregulation of Mcl-1, and inhibition of the Akt pathway. Therefore, VGE is a potent anti-cancer agent against lung cancer cells.

Footnotes

Source of support: Departmental sources

References

  • 1.Zhen QS, Ye X, Wei ZJ. Recent progress in research on Tripterygium: A male antifertility plant. Contraception. 1995;51:121–29. doi: 10.1016/0010-7824(94)00018-r. [DOI] [PubMed] [Google Scholar]
  • 2.Tengchaisri T, Chawengkirttikul R, Rachaphaew N, et al. Antitumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters. Cancer Lett. 1998;133:169–75. doi: 10.1016/s0304-3835(98)00222-5. [DOI] [PubMed] [Google Scholar]
  • 3.Asamura H, Goya T, Koshiishi Y, et al. A Japanese Lung Cancer Registry study: Prognosis of 13,010 resected lung cancers. J Thorac Oncol. 2008;3:46–52. doi: 10.1097/JTO.0b013e31815e8577. [DOI] [PubMed] [Google Scholar]
  • 4.Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997;111:1710–17. doi: 10.1378/chest.111.6.1710. [DOI] [PubMed] [Google Scholar]
  • 5.Tsuboi M, Ohira T, Saji H, et al. The present status of postoperative adjuvant chemotherapy for completely resected nonsmall cell lung cancer. Ann Thorac Cardiovasc Surg. 2007;13:73–77. [PubMed] [Google Scholar]
  • 6.Cohen JJ. Apoptosis. Immunol Today. 1993;14:126–30. doi: 10.1016/0167-5699(93)90214-6. [DOI] [PubMed] [Google Scholar]
  • 7.White E. Life, death, and the pursuit of apoptosis. Genes Dev. 1996;10:1–15. doi: 10.1101/gad.10.1.1. [DOI] [PubMed] [Google Scholar]
  • 8.Williams GT, Smith CA. Molecular regulation of apoptosis: Genetic controls on cell death. Cell. 1993;74:777–79. doi: 10.1016/0092-8674(93)90457-2. [DOI] [PubMed] [Google Scholar]
  • 9.Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980;68:251–306. doi: 10.1016/s0074-7696(08)62312-8. [DOI] [PubMed] [Google Scholar]
  • 10.Danial NN, Korsmeyer SJ. Cell death: Critical control points. Cell. 2004;116:205–19. doi: 10.1016/s0092-8674(04)00046-7. [DOI] [PubMed] [Google Scholar]
  • 11.Desagher S, Osen-Sand A, Nichols A, et al. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol. 1999;144:891–901. doi: 10.1083/jcb.144.5.891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Wei MC, Zong WX, Cheng EH, et al. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science. 2001;292:727–30. doi: 10.1126/science.1059108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Zong WX, Lindsten T, Ross AJ, et al. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 2001;15:1481–86. doi: 10.1101/gad.897601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Chen L, Willis SN, Wei A, et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell. 2005;17:393–403. doi: 10.1016/j.molcel.2004.12.030. [DOI] [PubMed] [Google Scholar]
  • 15.Kuwana T, Bouchier-Hayes L, Chipuk JE, et al. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell. 2005;17:525–35. doi: 10.1016/j.molcel.2005.02.003. [DOI] [PubMed] [Google Scholar]
  • 16.Nijhawan D, Fang M, Traer E, et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev. 2003;17:1475–86. doi: 10.1101/gad.1093903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Willis SN, Chen L, Dewson G, et al. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 2005;19:1294–305. doi: 10.1101/gad.1304105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Germain M, Milburn J, Duronio V. MCL-1 inhibits BAX in the absence of MCL-1/BAX Interaction. J Biol Chem. 2008;283:6384–92. doi: 10.1074/jbc.M707762200. [DOI] [PubMed] [Google Scholar]
  • 19.Zhang S, Li T, Zhang L, et al. A novel chalcone derivative S17 induces apoptosis through ROS dependent DR5 up regulation in gastric cancer cells. Sci Rep. 2017;7:9873. doi: 10.1038/s41598-017-10400-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Deligia F, Murineddu G, Gotti C, et al. Pyridinyl- and pyridazinyl-3,6-diazabicyclo[3.1.1]heptane-anilines: Novel selective ligands with subnanomolar affinity for α4β2 nACh receptors. Eur J Med Chem. 2018;152:401–16. doi: 10.1016/j.ejmech.2018.04.026. [DOI] [PubMed] [Google Scholar]
  • 21.Deligia F, Deiana V, Gotti C, et al. Design of novel 3,6-diazabicyclo[3.1.1]heptane derivatives with potent and selective affinities for a4b2 neuronal nicotinic acetylcholine receptors. Eur J Med Chem. 2015;103:429–37. doi: 10.1016/j.ejmech.2015.09.006. [DOI] [PubMed] [Google Scholar]
  • 22.Song G, Ouyang G, Bao S. The activation of Akt/PKB signalling pathway and cell survival. J Cell Mol Med. 2005;9:59–71. doi: 10.1111/j.1582-4934.2005.tb00337.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.McCubrey JA, Steelman LS, Abrams SL, et al. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance. Adv Enzyme Regul. 2006;46:249–79. doi: 10.1016/j.advenzreg.2006.01.004. [DOI] [PubMed] [Google Scholar]
  • 24.Shi X, Jin Y, Cheng C, et al. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Clin Cancer Res. 2009;15:1686–97. doi: 10.1158/1078-0432.CCR-08-2141. [DOI] [PubMed] [Google Scholar]
  • 25.Yang M, Huang J, Pan HZ, Jin J. Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells. Int J Mol Med. 2008;22:489–96. [PubMed] [Google Scholar]
  • 26.Fulda S, Debatin KM. Apoptosis signalling in tumor therapy. Ann NY Acad Sci. 2004;1028:150–56. doi: 10.1196/annals.1322.016. [DOI] [PubMed] [Google Scholar]
  • 27.Fulda S, Debatin KM. Targeting apoptosis pathways in cancer therapy. Curr Cancer Drug Targets. 2004;4:569–76. doi: 10.2174/1568009043332763. [DOI] [PubMed] [Google Scholar]
  • 28.Cohen GM. Caspases: The executioners of apoptosis. Biochem J. 1997;326:1–16. doi: 10.1042/bj3260001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Adams JM, Cory S. The Bcl-2 protein family: Arbiters of cell survival. Science. 1998;281:1322–26. doi: 10.1126/science.281.5381.1322. [DOI] [PubMed] [Google Scholar]
  • 30.Zhang B, Gojo I, Fenton RG. Myeloid cell factor-1 is a critical survival factor for multiple myeloma. Blood. 2002;99:1885–93. doi: 10.1182/blood.v99.6.1885. [DOI] [PubMed] [Google Scholar]
  • 31.Festjens N, van Gurp M, van Loo G, et al. Bcl-2 family members as sentinels of cellular integrity and role of mitochondrial intermembrane space proteins in apoptotic cell death. Acta Haematologica. 2004;111:7–27. doi: 10.1159/000074483. [DOI] [PubMed] [Google Scholar]
  • 32.Clohessy JG, Zhuang J, de Boer J, et al. Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis. J Biol Chem. 2006;281:5750–59. doi: 10.1074/jbc.M505688200. [DOI] [PubMed] [Google Scholar]

Articles from Medical Science Monitor : International Medical Journal of Experimental and Clinical Research are provided here courtesy of International Scientific Information, Inc.

RESOURCES